Hyaluronic acid reduction-sensitive polymeric micelles achieving co-delivery of tumor-targeting paclitaxel/apatinib effectively reverse cancer multidrug resistance

• Egile Nagusiak: Xiaoqing Zhang (Egilea), Xiaomei Ren (Egilea), Jiayin Tang (Egilea), Jiangtao Wang (Egilea), Xiang Zhang (Egilea), Peng He (Egilea), Chang Yao (Egilea), Weihe Bian (Egilea), Lizhu Sun (Egilea)
• Formatua: Liburua
• Argitaratua: Taylor & Francis Group, 2020-01-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

Multidrug resistance (MDR) of cancer cells is a significant challenge in chemotherapy, highlighting the urgent medical need for simple and reproducible strategies to reverse this process. Here, we report the development of an active tumor-targeting and redox-responsive nanoplatform (PA-ss-NP) using...